| #400 |
Jeeyoung Choi |
Align Technology |
1 |
| #400 |
Soohyung Kim |
Samsung |
1 |
| #400 |
Daniel Hochbaum |
Harvard University |
1 |
| #400 |
Justin Matthew Verdirame |
Asml Holding N.V. |
1 |
| #400 |
Ignacio Galiana Bujanda |
— |
1 |
| #400 |
Bryan McLaughlin |
Draper Laboratory |
1 |
| #400 |
Ruffin Evans |
Google |
1 |
| #400 |
Manu Prakash |
MIT |
1 |
| #400 |
Samuel M. Nicaise |
University of Pennsylvania |
1 |
| #400 |
Timothy Milakovich |
MIT |
1 |
| #400 |
Diana Katharine Hunt |
Tetraphase Pharmaceuticals |
1 |
| #400 |
Kayo Yasoshima |
Novartis Ag |
1 |
| #400 |
Matt Garcia |
Bandwidth |
1 |
| #400 |
David Allen Annis |
Aileron Therapeutics |
1 |
| #400 |
Viswanathan Sasisekharan |
MIT |
1 |
| #400 |
Michael Philip Short |
MIT |
1 |
| #400 |
Arrin Katz |
Thermo Fisher |
1 |
| #400 |
Orad Reshef |
Harvard University |
1 |
| #400 |
Linda G. Griffith |
MIT |
1 |
| #400 |
Sarah F. Frisken |
Mitsubishi Electric |
1 |
| #400 |
Noel Marie-France Thomsen |
Novartis Ag |
1 |
| #400 |
Michael Roguska |
Novartis Ag |
1 |
| #400 |
Michael Paul Capparelli |
Novartis Ag |
1 |
| #400 |
Luciano Boglione |
US Air Force |
1 |
| #400 |
Joseph Walish |
MIT |
1 |
| #400 |
Daniel E. Smalley |
MIT |
1 |
| #400 |
Marc W. Regan |
Microsoft |
1 |
| #400 |
Alexander V. Kelin |
Alnylam Pharmaceuticals |
1 |
| #400 |
Georgia Giannoukos |
MIT |
1 |
| #400 |
David Steinmiller |
Opko Diagnostics |
1 |
| #400 |
Timothy F. BRIGGS |
Flagship Pioneering Innovations Vi |
1 |
| #400 |
Vivek Sikri |
Applied Medical Resources |
1 |
| #400 |
John J. Zayhowski |
MIT |
1 |
| #400 |
Pangus Ho |
Oracle |
1 |
| #400 |
Deborah Hung |
The Broad Institute |
1 |
| #400 |
Neil Vasdev |
The General Hospital |
1 |
| #400 |
Jose Gomez-Marquez |
MIT |
1 |
| #400 |
Ludwig Schmidt |
Google |
1 |
| #400 |
Andres D. Molina-Markham |
Emc Ip Holding Company |
1 |
| #400 |
James Jeiwen Chou |
Dana-Farber Cancer Institute |
1 |
| #400 |
Daniel F. Gaddy |
Merrimack Pharmaceuticals |
1 |
| #400 |
Peter M. Jones |
IBM |
1 |
| #400 |
Tatiana Novobrantseva |
Alnylam Pharmaceuticals |
1 |
| #400 |
Florian Karpfinger |
Schlumberger Technology |
1 |
| #400 |
Ashok Ajoy |
University of California |
1 |
| #400 |
Alexander Meissner |
Harvard University |
1 |
| #400 |
Lucas Waye |
Rovi Guides |
1 |
| #400 |
Conor J. Walsh |
Harvard University |
1 |
| #400 |
Jianlin Guo |
Mitsubishi Electric |
1 |
| #400 |
Michael Scott Visser |
Novartis Ag |
1 |